Aplantex onboards Patrick Charest as CEO

335

The board of directors of Aplantex is pleased to announce the nomination of Mr. Patrick Charest, B. Sc, P. Eng. as CEO of the company.

With over 25 years of experience in supporting the growth of leading private sector organizations, Patrick is a dynamic and inspiring leader with a unique ability to envision and implement successful growth strategies. Distinctively, Patrick is an engineer whose entire career has been dedicated to business development and growth-oriented activities. Strong from his long corporate experience, Patrick jumped the corporate/private fence in early 2020 to contribute to the start-up of a Calgary-based artificial intelligence and data analytics company. “Following this successful experience and now fueled by the contagious momentum of the start-up world, it was just natural to have him take the leadership of another promising start-up this one in the Biotechnology realm” underlines Mr. Mourad Sabri, Aplantex founder, and shareholder. Patrick holds a Biotechnology degree from Sherbrooke University as well as a Chemical Engineering degree from the same institution. He is currently enrolled in the Mini-MBA program at McGill University. He is a registered member of Ordre des Ingénieurs du Québec.

“Sharing Aplantex’s vision of efficiently using its innovative green biotechnology process, it is with enthusiasm that I add my skills to those of the team to improve the availability of phytochemical elements essential to the production of health, beauty, and food products that have a positive impact on the well-being of people,” says Mr. Charest. “Aplantex is now in full growth mode, and we are committed at providing high-value molecules at a lower cost compared to the other production processes while simplifying the supply chain and working within ESG principles,” concludes Mr. Charest.

Source

For more news and updates pertaining to green biotechnology below mentioned are some articles:

Hyfe Foods gets USD 2 million in pre-seed investments

Akston Biosciences appoints John T. Preston as Board of Directors